• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Antibiotics for secondary prevention of coronary artery disease: an ACES hypothesis but we need to PROVE IT.

作者信息

Gelfand Eli V, Cannon Christopher P

机构信息

Cardiovascular Division, Beth Israel Deaconess Medical Center, Boston, Mass, USA.

出版信息

Am Heart J. 2004 Feb;147(2):202-9. doi: 10.1016/j.ahj.2003.09.011.

DOI:10.1016/j.ahj.2003.09.011
PMID:14760314
Abstract
摘要

相似文献

1
Antibiotics for secondary prevention of coronary artery disease: an ACES hypothesis but we need to PROVE IT.抗生素用于冠状动脉疾病的二级预防：ACES假说，但我们需要加以证实。
Am Heart J. 2004 Feb;147(2):202-9. doi: 10.1016/j.ahj.2003.09.011.
2
Chlamydia pneumoniae and acute coronary syndrome.肺炎衣原体与急性冠状动脉综合征
N Engl J Med. 2005 Aug 4;353(5):525-8; author reply 525-8. doi: 10.1056/NEJM200508043530518.
3
Infection, antibiotics, and atherothrombosis--end of the road or new beginnings?感染、抗生素与动脉粥样硬化血栓形成——终点还是新起点？
N Engl J Med. 2005 Apr 21;352(16):1706-9. doi: 10.1056/NEJMe058019.
4
Chlamydia pneumoniae and acute coronary syndrome.肺炎衣原体与急性冠状动脉综合征
N Engl J Med. 2005 Aug 4;353(5):525-8; author reply 525-8.
5
[Final confirmation of inefficiency of antibiotics in secondary prevention of coronary heart disease. Results of PROVE IT (gatifloxacin trial) and ACES].
Kardiologiia. 2004;44(10):82-3.
6
Antibiotics and coronary heart disease.抗生素与冠心病
JAMA. 2004 Jan 21;291(3):302-3; author reply 303. doi: 10.1001/jama.291.3.302-b.
7
Chlamydia pneumoniae and acute coronary syndrome.肺炎衣原体与急性冠状动脉综合征
N Engl J Med. 2005 Aug 4;353(5):525-8; author reply 525-8.
8
Chlamydia pneumoniae and coronary artery disease: the antibiotic trials.肺炎衣原体与冠状动脉疾病：抗生素试验
Mayo Clin Proc. 2003 Mar;78(3):321-32. doi: 10.4065/78.3.321.
9
Antibiotics and heart disease. The story heats up.
Harv Heart Lett. 1999 Jul;9(11):4-6.
10
[Chlamydia pneumoniae and myocardial infarction (CLINF). Preliminary randomized controlled study with clarithromycin. CLAINF protocol].
Minerva Cardioangiol. 2000 Dec;48(12):411-25.

引用本文的文献

1
The role of the gut microbiota and its metabolites: a new predictor in diabetes and its complications.肠道微生物群及其代谢产物的作用：糖尿病及其并发症的新预测指标。
Eur J Med Res. 2025 Jul 9;30(1):601. doi: 10.1186/s40001-025-02824-9.
2
The potential of tailoring the gut microbiome to prevent and treat cardiometabolic disease.调整肠道微生物群以预防和治疗心血管代谢疾病的潜力。
Nat Rev Cardiol. 2023 Apr;20(4):217-235. doi: 10.1038/s41569-022-00771-0. Epub 2022 Oct 14.
3
Randomised placebo controlled multicentre trial to assess short term clarithromycin for patients with stable coronary heart disease: CLARICOR trial.
评估短期使用克拉霉素治疗稳定型冠心病患者的随机安慰剂对照多中心试验：CLARICOR试验
BMJ. 2006 Jan 7;332(7532):22-7. doi: 10.1136/bmj.38666.653600.55. Epub 2005 Dec 8.
4
Antibiotics active against Chlamydia do not reduce the risk of myocardial infarction.对衣原体有效的抗生素不会降低心肌梗死的风险。
Eur J Clin Pharmacol. 2006 Jan;62(1):43-9. doi: 10.1007/s00228-005-0059-x. Epub 2005 Dec 6.
5
Chlamydia pneumoniae and atherosclerosis: from Koch postulates to clinical trials.肺炎衣原体与动脉粥样硬化：从科赫法则到临床试验
Prog Cardiovasc Dis. 2005 Jan-Feb;47(4):230-9. doi: 10.1016/j.pcad.2005.01.001.